Ocugen Inc. is a biopharmaceutical company that develops gene therapies for rare and underserved diseases. Their innovative approach to treating previously untreatable conditions has earned them widespread recognition and success. With a strong focus on research and development, Ocugen Inc. continues to push boundaries in the medical field.
